Back to discover
Disease
Reinfection
Clinical development underwayEmerging research
2
Publications
1
Clinical trials
1
Related conditions
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
Research2022-11-10Nature medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
0
0
0
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20212022
Most influential
Major themes2
- COVID-192
- SARS-CoV-22
Leading journals2
- BMC infectious diseases1
- Nature medicine1
Leading researchers8
- Al-Aly Z1
- Bogoch II1
- Bowe B1
- Escandón K1
- Kindrachuk J1
- Murray EJ1
- Popescu SV1
- Rasmussen AL1
Affiliations (unnormalised)6
- Boston University School of Public Health1
- Clinical Epidemiology Center1
- Georgetown Center for Global Health Science and Security1
- Institute for Public Health1
- Schar School of Policy and Government1
- School of Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Infection by the same infectious agent following a recovery. Reinfection may be by a different strain or the same strain.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.